Publikationen 2012
Originalarbeiten
Versorgungsprozesse der Psoriasis in Deutschland – Langzeitanalyse von Sekundärdaten der gesetzlichen Krankenversicherung [Processes of Psoriasis Health Care in Germany – Long-Term Analysis of Data from the Statutory Health Insurances], Augustin M, Glaeske G, Schaefer I, Rustenbach SJ, Hoer A, Radtke MA. J Dtsch Dermatol Ges 2012; 10 (9): 648–655, PubMed-Link
Etanercept in der Therapie der juvenilen Psoriasis [Etanercept in Juvenile Psoriasis], Beikert FC, Augustin M, Radtke MA. Hautarzt 2012; 63 (5): 406–410, PubMed-Link
Validation of the Patient Benefit Index for the Assessment of Patient- Relevant Benefit in the Treatment of Psoriasis, Feuerhahn J, Blome C, Radtke MA, Augustin M. Arch Dermatol Res 2012; 304 (6): 433–441, PubMed-Link
Quality of Psoriasis Care from the Patients‘ Perspective – Results of the National Health Care Study PsoReal , Langenbruch AK, Radtke MA, Augustin M. Eur J Dermatol 2012; 22(4): 518–524, PubMed-Link
Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis Therapies, Ormerod AD, Augustin M, Baker C, Chosidow O, Cohen AD, Dam TN, Garcia-Doval I, Lecluse LL, Schmitt-Egenolf M, Spuls PI, Watson KD, Naldi L. Dermatology 2012; 224 (3): 236–243, PubMed-Link
Übersichtsartikel, Weiterbildung, Editorials
Psoriasis White Paper – A Framework for Improving the Quality of Care for People with Psoriasis, Augustin M, Alvaro-Gracia JM, Bagot M, Hillmann O, van de Kerkhof PCM, Kobelt G, Maccarone M, Naldi L, Schellekens H. J Eur Acad Dermatol Venereol 2012; 26 (Suppl 4): 1–16, PubMed-Link
German S3 – Guidelines on the Treatment of Psoriasis Vulgaris (Short Version), Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Mueller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B. Arch Dermatol Res 2012; 304 (2): 87–113, PubMed-Link
German S3 – Guidelines on the Treatment of Psoriasis Vulgaris (English Version). Update , Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Koza J, Mueller S, Orzechowski HD, Rosumeck S, Schmid-Ott G, Weberschock T, Rzany B. J Dtsch Dermatol Ges 2012; 10 (Suppl 2): S1–S95, PubMed-Link
PSOLAR: Design, Utility, and Preliminary Results of a Prospective, International, Disease-based Registry of Patients with Psoriasis who are Receiving, or are Candidates for, Conventional Systemic Treatments or Biologic Agents, Papp KA, Strober B, Augustin M, Calabro S, Londhe A, Chevrier M. Dermatol 2012; 11 (10): 1210–1217, PubMed-Link